387 related articles for article (PubMed ID: 27193339)
1. Distinct white-matter aberrations in 22q11.2 deletion syndrome and patients at ultra-high risk for psychosis.
Bakker G; Caan MW; Schluter RS; Bloemen OJ; da Silva-Alves F; de Koning MB; Boot E; Vingerhoets WA; Nieman DH; de Haan L; Booij J; van Amelsvoort TA
Psychol Med; 2016 Aug; 46(11):2299-311. PubMed ID: 27193339
[TBL] [Abstract][Full Text] [Related]
2. Abnormalities in brain white matter in adolescents with 22q11.2 deletion syndrome and psychotic symptoms.
Kikinis Z; Cho KIK; Coman IL; Radoeva PD; Bouix S; Tang Y; Eckbo R; Makris N; Kwon JS; Kubicki M; Antshel KM; Fremont W; Shenton ME; Kates WR
Brain Imaging Behav; 2017 Oct; 11(5):1353-1364. PubMed ID: 27730479
[TBL] [Abstract][Full Text] [Related]
3. White matter microstructural deficits in 22q11.2 deletion syndrome.
Roalf DR; Eric Schmitt J; Vandekar SN; Satterthwaite TD; Shinohara RT; Ruparel K; Elliott MA; Prabhakaran K; McDonald-McGinn DM; Zackai EH; Gur RC; Emanuel BS; Gur RE
Psychiatry Res Neuroimaging; 2017 Oct; 268():35-44. PubMed ID: 28865345
[TBL] [Abstract][Full Text] [Related]
4. Cortical Morphology Differences in Subjects at Increased Vulnerability for Developing a Psychotic Disorder: A Comparison between Subjects with Ultra-High Risk and 22q11.2 Deletion Syndrome.
Bakker G; Caan MW; Vingerhoets WA; da Silva-Alves F; de Koning M; Boot E; Nieman DH; de Haan L; Bloemen OJ; Booij J; van Amelsvoort TA
PLoS One; 2016; 11(11):e0159928. PubMed ID: 27828960
[TBL] [Abstract][Full Text] [Related]
5. White matter microstructure in ultra-high risk and first episode schizophrenia: A prospective study.
Rigucci S; Santi G; Corigliano V; Imola A; Rossi-Espagnet C; Mancinelli I; De Pisa E; Manfredi G; Bozzao A; Carducci F; Girardi P; Comparelli A
Psychiatry Res Neuroimaging; 2016 Jan; 247():42-8. PubMed ID: 26651180
[TBL] [Abstract][Full Text] [Related]
6. Altered white matter microstructure in 22q11.2 deletion syndrome: a multisite diffusion tensor imaging study.
Villalón-Reina JE; Martínez K; Qu X; Ching CRK; Nir TM; Kothapalli D; Corbin C; Sun D; Lin A; Forsyth JK; Kushan L; Vajdi A; Jalbrzikowski M; Hansen L; Jonas RK; van Amelsvoort T; Bakker G; Kates WR; Antshel KM; Fremont W; Campbell LE; McCabe KL; Daly E; Gudbrandsen M; Murphy CM; Murphy D; Craig M; Emanuel B; McDonald-McGinn DM; Vorstman JAS; Fiksinski AM; Koops S; Ruparel K; Roalf D; Gur RE; Eric Schmitt J; Simon TJ; Goodrich-Hunsaker NJ; Durdle CA; Doherty JL; Cunningham AC; van den Bree M; Linden DEJ; Owen M; Moss H; Kelly S; Donohoe G; Murphy KC; Arango C; Jahanshad N; Thompson PM; Bearden CE
Mol Psychiatry; 2020 Nov; 25(11):2818-2831. PubMed ID: 31358905
[TBL] [Abstract][Full Text] [Related]
7. Patterns of white matter microstructure in individuals at ultra-high-risk for psychosis: associations to level of functioning and clinical symptoms.
Krakauer K; Ebdrup BH; Glenthøj BY; Raghava JM; Nordholm D; Randers L; Rostrup E; Nordentoft M
Psychol Med; 2017 Nov; 47(15):2689-2707. PubMed ID: 28464976
[TBL] [Abstract][Full Text] [Related]
8. Alterations in white matter microstructure and cortical thickness in individuals at ultra-high risk of psychosis: A multimodal tractography and surface-based morphometry study.
Tomyshev AS; Lebedeva IS; Akhadov TA; Omelchenko MA; Rumyantsev AO; Kaleda VG
Psychiatry Res Neuroimaging; 2019 Jul; 289():26-36. PubMed ID: 31132567
[TBL] [Abstract][Full Text] [Related]
9. White matter abnormalities in 22q11.2 deletion syndrome patients showing cognitive decline.
Nuninga JO; Bohlken MM; Koops S; Fiksinski AM; Mandl RCW; Breetvelt EJ; Duijff SN; Kahn RS; Sommer IEC; Vorstman JAS
Psychol Med; 2018 Jul; 48(10):1655-1663. PubMed ID: 29143717
[TBL] [Abstract][Full Text] [Related]
10. Altered structural network architecture is predictive of the presence of psychotic symptoms in patients with 22q11.2 deletion syndrome.
Padula MC; Scariati E; Schaer M; Sandini C; Ottet MC; Schneider M; Van De Ville D; Eliez S
Neuroimage Clin; 2017; 16():142-150. PubMed ID: 28794975
[TBL] [Abstract][Full Text] [Related]
11. Cortical morphology development in patients with 22q11.2 deletion syndrome at ultra-high risk of psychosis.
Padula MC; Schaer M; Armando M; Sandini C; Zöller D; Scariati E; Schneider M; Eliez S
Psychol Med; 2018 Oct; 48(14):2375-2383. PubMed ID: 29338796
[TBL] [Abstract][Full Text] [Related]
12. State-dependent microstructural white matter changes in drug-naïve patients with first-episode psychosis.
Serpa MH; Doshi J; Erus G; Chaim-Avancini TM; Cavallet M; van de Bilt MT; Sallet PC; Gattaz WF; Davatzikos C; Busatto GF; Zanetti MV
Psychol Med; 2017 Nov; 47(15):2613-2627. PubMed ID: 28826419
[TBL] [Abstract][Full Text] [Related]
13. Aberrant White Matter Microstructure in Children and Adolescents With the Subtype of Prader-Willi Syndrome at High Risk for Psychosis.
Lukoshe A; van den Bosch GE; van der Lugt A; Kushner SA; Hokken-Koelega AC; White T
Schizophr Bull; 2017 Sep; 43(5):1090-1099. PubMed ID: 28510708
[TBL] [Abstract][Full Text] [Related]
14. Abnormalities in white matter tracts in the fronto-striatal-thalamic circuit are associated with verbal performance in 22q11.2DS.
Heller C; Steinmann S; Levitt JJ; Makris N; Antshel KM; Fremont W; Coman IL; Schweinberger SR; Weiß T; Bouix S; Kubicki MR; Kates WR; Kikinis Z
Schizophr Res; 2020 Oct; 224():141-150. PubMed ID: 33268158
[TBL] [Abstract][Full Text] [Related]
15. Altered white matter microstructure is associated with social cognition and psychotic symptoms in 22q11.2 microdeletion syndrome.
Jalbrzikowski M; Villalon-Reina JE; Karlsgodt KH; Senturk D; Chow C; Thompson PM; Bearden CE
Front Behav Neurosci; 2014; 8():393. PubMed ID: 25426042
[TBL] [Abstract][Full Text] [Related]
16. Implication of reward alterations in the expression of negative symptoms in 22q11.2 deletion syndrome: a behavioural and DTI study.
Dubourg L; Schneider M; Padula MC; Chambaz L; Schaer M; Eliez S
Psychol Med; 2017 Jun; 47(8):1442-1453. PubMed ID: 28112057
[TBL] [Abstract][Full Text] [Related]
17. Machine-learning classification of 22q11.2 deletion syndrome: A diffusion tensor imaging study.
Tylee DS; Kikinis Z; Quinn TP; Antshel KM; Fremont W; Tahir MA; Zhu A; Gong X; Glatt SJ; Coman IL; Shenton ME; Kates WR; Makris N
Neuroimage Clin; 2017; 15():832-842. PubMed ID: 28761808
[TBL] [Abstract][Full Text] [Related]
18. Changes in negative symptoms are linked to white matter changes in superior longitudinal fasciculus in individuals at ultra-high risk for psychosis.
Kristensen TD; Glenthøj LB; Raghava JM; Syeda W; Mandl RCW; Wenneberg C; Krakauer K; Fagerlund B; Pantelis C; Glenthøj BY; Nordentoft M; Ebdrup BH
Schizophr Res; 2021 Nov; 237():192-201. PubMed ID: 34543833
[TBL] [Abstract][Full Text] [Related]
19. White-matter markers for psychosis in a prospective ultra-high-risk cohort.
Bloemen OJ; de Koning MB; Schmitz N; Nieman DH; Becker HE; de Haan L; Dingemans P; Linszen DH; van Amelsvoort TA
Psychol Med; 2010 Aug; 40(8):1297-304. PubMed ID: 19895720
[TBL] [Abstract][Full Text] [Related]
20. White matter maturation during 12 months in individuals at ultra-high-risk for psychosis.
Krakauer K; Nordentoft M; Glenthøj BY; Raghava JM; Nordholm D; Randers L; Glenthøj LB; Ebdrup BH; Rostrup E
Acta Psychiatr Scand; 2018 Jan; 137(1):65-78. PubMed ID: 29143980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
